HAS Healthcare Advanced Synthesis SA
Contract Development & Manufacturing (CDMO) · Biasca, Ticino
HAS Healthcare Advanced Synthesis SA is a Swiss contract development & manufacturing (CDMO) company based in Biasca, Canton of Ticino (UID CHE-108.129.247).
Board members & signatories
- Paolo Bottini
- Giacomo Braglia
- Riccardo Braglia
Registered purpose
La Società ha come scopo la fabbricazione e la commercializzazione di prodotti chimici e affini sia in proprio che per rappresentanza o commissione e lo sfruttamento di licenze e brevetti nel settore chimico, farmaceutico, parafarmaceutico, veterinario e settori affini. In generale la Società può espletare ogni operazione finanziaria e commerciale necessaria o utile per il conseguimento dello scop…
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What HAS Healthcare Advanced Synthesis does
OFFERING
HAS Healthcare Advanced Synthesis provides contract development and manufacturing services for Active Pharmaceutical Ingredients (APIs), Highly Potent APIs (HPAPIs), and Anticancer compounds. Their facilities are equipped to handle production from clinical to commercial scales, ensuring compliance with cGMP standards. They also offer services in lab development, regulatory approval, and analytical support for clients in the pharmaceutical industry.
Unlock the full analysis →Similar companies
- Farmak AG — Pharmaceuticals · Baar
- HSF PHARMACEUTICALS SA — Pharmaceuticals · Villarsel-Gibloux
- Jetpharma SA — Contract Development & Manufacturing (CDMO) · Balerna
- Pharmaserv AG — Pharmaceuticals · Stansstad
- Flarer SA — Pharmaceuticals · Balerna
- GMT Fine Chemicals SA — Pharmaceuticals · Couvet
Find every contract development & manufacturing (CDMO) company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned contract development & manufacturing (CDMO) companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime